BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/25/2020 9:45:46 AM | Browse: 591 | Download: 927
 |
Received |
|
2020-05-26 09:16 |
|
Peer-Review Started |
|
2020-05-26 09:17 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-06-13 04:55 |
|
Revised |
|
2020-06-24 03:19 |
|
Second Decision |
|
2020-07-22 10:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-07-23 01:54 |
|
Articles in Press |
|
2020-07-23 01:54 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-07-27 19:16 |
|
Typeset the Manuscript |
|
2020-08-03 14:54 |
|
Publish the Manuscript Online |
|
2020-08-25 09:45 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zheng Guo, Jing Wang, Li Li, Rong Liu, Jin Fang and Bin Tie |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bin Tie, MAMS, Attending Doctor, Interventional Medicine, The First Hospital of Lanzhou University, No. 1, Donggang West Road, Lanzhou 730000, Gansu Province, China. tie12bin@163.com |
| Key Words |
miR-1271; Glypican-3; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Teal-time quantitative polymerase chain reaction; Tumor recurrence |
| Core Tip |
The results of this study prove that the serum GPC3 level in patients with hepatocellular carcinoma recurrence after transcatheter arterial chemoembolization is significantly higherthan Remission group, and miR-1271 is significantly lower. The combined detection of serum GPC3 and miR-1271 has an important clinical reference value for evaluating the prognosis of hepatocellular carcinoma, Serum GPC3 and miR-1271 levels can help determine tumor recurrence, prognosis evaluation. |
| Publish Date |
2020-08-25 09:45 |
| Citation |
Guo Z, Wang J, Li L, Liu R, Fang J, Tie B. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Clin Cases 2020; 8(16): 3493-3502 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i16/3493.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i16.3493 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
